SCHEMBL2475121

SCHEMBL2475121

O=c1cc(O)c2c(F)cccc2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 3/20 0.38
GAA P10253 3/20 0.38
HPGD P15428 3/20 0.38
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
DAO P14920 2/20 0.37
DDO Q99489 2/20 0.37
SLC9A1 P19634 1/20 0.36
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
PRNP P04156 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL467777 0.69 ALDH1A1 (0.55) ALDH1A1KDM4EGAAMAOAMAOB
SCHEMBL28388316 0.69 SMN1; SMN2 (0.36) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL2472396 0.69 MAOA (0.46) ALDH1A1MAOAMAOBNPC1RAB9A
SCHEMBL28999318 0.67 ALDH1A1 (0.37) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL28341626 0.67 ALDH1A1 (0.37) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL28596766 0.67 ALDH1A1 (0.39) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL6927135 0.67 ERN1 (0.46) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL5342252 0.66 CA9 (0.55) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL20262961 0.66 MAPT (0.50) ALDH1A1KDM4EGAAHPGDMAOA
SCHEMBL25299642 0.64 MAPK1 (0.51) ALDH1A1KDM4EGAAHPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370422-B1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN INC (US) 2019-06-05 EP disclosed
US-9149476-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-10-06 US disclosed
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. 2015-07-02 US disclosed
US-8927591-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-01-06 US disclosed
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2011-12-15 US disclosed
EP-2370422-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS Fibrogen, Inc. (US) 2011-10-05 EP disclosed
WO-2010056767-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 ALDH1A1 240/4885KDM4E 942/4885GAA 332/4885
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 ALDH1A1 240/4885KDM4E 942/4885GAA 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.